Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 751 AL 765

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly

Gras-Miralles B, Cremonini F.

Clin Interv Aging. 2013;8:191-200. doi: 10.2147/CIA.S30729. Epub 2013 Feb 15.

Mitochondria as a pharmacological target: magnum overview

Olszewska A, Szewczyk A.

IUBMB Life. 2013 Mar;65(3):273-81. doi: 10.1002/iub.1147.

Validation and cross-cultural adaptation of the Falls Efficacy Scale in patients with Parkinson's disease in Serbia

Gazibara T, Stankovic I, Tomic A, Svetel M, Tepavcevic DK, Kostic VS, Pekmezovic T.

Geriatr Gerontol Int. 2013 Oct;13(4):936-41. doi: 10.1111/ggi.12034. Epub 2013 Feb 26.

Neurotransmitters and microglial-mediated neuroinflammation

Lee M.

Curr Protein Pept Sci. 2013 Feb;14(1):21-32. doi: 10.2174/1389203711314010005.

Peroxiredoxin 5 links mitochondrial redox signalling with calcium dynamics: impact on Parkinson's disease

Davey GP, Bolaños JP.

J Neurochem. 2013 May;125(3):332-3. doi: 10.1111/jnc.12171. Epub 2013 Feb 27.

Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease

van der Vegt JP, Hulme OJ, Zittel S, Madsen KH, Weiss MM, Buhmann C, Bloem BR, Münchau A, Siebner HR.

Brain. 2013 Apr;136(Pt 4):1192-203. doi: 10.1093/brain/awt027. Epub 2013 Feb 26.

Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease

Chiaravalloti A, Stefani A, Di Biagio D, Pierantozzi M, Tavolozza M, Di Pietro B, Stanzione P, Schillaci O.

Ann Nucl Med. 2013 Jun;27(5):444-51. doi: 10.1007/s12149-013-0702-z. Epub 2013 Feb 27.

Cardiovascular and mortality risks in Parkinson's disease patients treated with entacapone

Graham DJ, Williams JR, Hsueh YH, Calia K, Levenson M, Pinheiro SP, Macurdy TE, Shih D, Worrall C, Kelman JA.

Mov Disord. 2013 Apr;28(4):490-7. doi: 10.1002/mds.25351. Epub 2013 Feb 26.

Epigenetic mechanisms in the development and maintenance of dopaminergic neurons

van Heesbeen HJ, Mesman S, Veenvliet JV, Smidt MP.

Development. 2013 Mar;140(6):1159-69. doi: 10.1242/dev.089359.

Validity of subthalamic-cortical coherency observed in patients with Parkinson's disease

Bock A, Kühn AA, Trahms L, Sander TH.

Biomed Tech (Berl). 2013 Apr;58(2):157-64. doi: 10.1515/bmt-2012-0023.

New Prophylactic and Therapeutic Strategies for Spinal Cord Injury

Park S, Park K, Lee Y, Chang KT, Hong Y.

J Lifestyle Med. 2013 Mar;3(1):34-40. Epub 2013 Mar 31.

Anxiety and depression in patients with Parkinson's disease

Yamanishi T, Tachibana H, Oguru M, Matsui K, Toda K, Okuda B, Oka N.

Intern Med. 2013;52(5):539-45. doi: 10.2169/internalmedicine.52.8617. Epub 2013 Mar 1.

Recent gene therapy advancements for neurological diseases

Nagabhushan Kalburgi S, Khan NN, Gray SJ.

Discov Med. 2013 Feb;15(81):111-9.

Is gait speed a valid measure to predict community ambulation in patients with Parkinson's disease?

Elbers RG, van Wegen EE, Verhoef J, Kwakkel G.

J Rehabil Med. 2013 Apr;45(4):370-5. doi: 10.2340/16501977-1123.

Anatomical and functional connectivity as a tool to study brain networks in Parkinson's disease

Strafella AP.

Mov Disord. 2013 Apr;28(4):411-2. doi: 10.1002/mds.25320. Epub 2013 Feb 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias